InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+10.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by BRODSKY JEFFREY S, Director. Insider active across 2 companies, notably Accolade, Inc.. Cumulatively, 20 reports have been recorded. Activity tracked since 2 December 2024. The latest transaction was disclosed on 8 April 2025 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations20 total
46,810 shares@ US$7.03100.0% of flowCommon StockSEC:0001415889-25-010343:0
2,178 shares0Common StockSEC:0001127602-25-007719:0
2,179 shares0Common StockSEC:0001127602-24-028583:0
2,179 sharesCommon StockSEC:0001127602-24-023511:0
9,196 sharesCommon StockSEC:0001127602-24-021881:0
2,179 sharesCommon StockSEC:0001127602-24-017165:0
1,751 sharesCommon StockSEC:0001127602-24-007981:0
1,751 sharesCommon StockSEC:0001127602-23-028681:0
1,752 sharesCommon StockSEC:0001127602-23-023468:0
14,060 sharesCommon StockSEC:0001127602-23-021385:0
1,752 sharesCommon StockSEC:0001127602-23-017342:0
1,207 sharesCommon StockSEC:0001127602-23-008182:0
1,207 sharesCommon StockSEC:0001127602-22-026672:0
1,207 sharesCommon StockSEC:0001127602-22-021873:0
2,659 sharesCommon StockSEC:0001127602-22-019731:0
1,207 sharesCommon StockSEC:0001127602-22-016270:0
346 sharesCommon StockSEC:0001127602-21-022477
346 sharesCommon StockSEC:0001127602-21-022477:0
27,842.08 sharesCommon StockSEC:0001209191-16-093108:0
15,330 sharesCommon StockSEC:0001209191-16-093108:1
20 of 20 declarations
About BRODSKY JEFFREY S
Brodsky Jeffrey S is a Director at Accolade, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the health and technology sectors allows him to provide valuable strategic insights. Jeffrey is committed to supporting Accolade's mission and promoting innovation in healthcare.
